Work

[ 18 F]Flortaucipir binding and affinity to tau protein measured in postmortem human brains of Alzheimer’s disease and Down syndrome by autoradiography: Comparison with [ 18 F]MK-6240

Year: 2026
Type: preprint
Abstract: Flortaucipir and MK-6240 are two tau imaging agents currently in use for measuring neurofibrillary tangle (NFT) progression in Alzheimer’s disease (AD). The aims of this study were to use postmortem AD and Down syndrome (DS) brain sections to study three issues: (1) Measure binding affinity of flortaucipir and MK-6240 in AD brain sections by using [ 125 I]IPPI; (2) Evaluate the binding characteristics of [ 18 F]flortaucipir in AD, DS and cognitively normal (CN) brains sections and compare them with [ 18 F]MK-6240, and (3) Assess the binding of [ 18 F]flortaucipir in CN and Parkinson’s disease (PD) brain sections to identify any off-target binding. The half-maximal inhibition (IC50) of [ 125 I]IPPI bound to anterior cingulate (AC) in AD brain sections for flortaucipir was 2.91 nM and MK-6240 was 5.99 nM. Using frontal cortex (FCX) and temporal cortex (TCX) of AD, DS and CN brain sections, [ 18 F]flortaucipir displayed high levels of binding in the gray matter (GM) of AD and DS. The average ratio of DSAD GM to CN GM was 15.7 in FCX, while DSAD GM to CN GM was 15.2 for the TCX. In the case of AD, average ratio of AD GM to CN GM was 12.4 in FCX, while AD GM to CN GM was 9.5 for the TCX. Binding of [ 18 F]flortaucipir in brain section of AC from CN and PD cases did not exhibit any off-target binding to monoamine oxidase-A (MAO-A). In summary, both flortaucipir and MK-6240 exhibit similar high affinity to tau and [ 18 F]flortaucipir exhibits higher binding compared to [ 18 F]MK-6240 in DSAD.
Language: English
Open Access status: green
OpenAlex ID: W7235753921
Cites: 55
Cited by:
Related to: 10